With a robust background in technology and healthcare investments, the fund manager has successfully executed over 50 deals across North America and Europe. Emphasizing a data-driven approach, they have built a diverse portfolio that includes notable exits in the biotech and SaaS sectors. Their strategic style prioritizes early-stage investments, leveraging operational expertise to support growth. Additionally, they are recognized for fostering strong relationships with founders, ensuring alignment and shared vision throughout the investment process.